Immune-metabolic status improvement in cancer therapy.
The authors present new trends in cancer therapy and discuss the intralymphocytic regulation of cGMP/cAMP ratio. It is suggested that proimmunity therapy results in improvement of immune surveillance in neoplasia.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000242:Cyclic AMP / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors; D006801:Humans; D007121:Immunocompetence / Q000187:drug effects; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011448:Prostaglandin Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D013601:T-Lymphocytes
D000276:Adjuvants, Immunologic; D016861:Cyclooxygenase Inhibitors; D011448:Prostaglandin Antagonists; D000242:Cyclic AMP; D006152:Cyclic GMP